Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Juvenile dermatomyositis.

The Journal of Rheumatology. Supplement

|April 1, 1992

Summary

This summary is machine-generated.

Juvenile dermatomyositis is a rare autoimmune disease causing muscle weakness and rash. Early treatment with corticosteroids is crucial for managing inflammation and improving outcomes, though complications can still arise.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Still's Disease Followed into Adult Life.

Proceedings of the Royal Society of Medicine·2010

Same author

Sarcoidosis in the pediatric age.

Clinical and experimental rheumatology·2002

Same author

Rheumatic disease mimics in childhood.

Current opinion in rheumatology·2000

Same author

Bone mineral content and bone mineral metabolism: changes after growth hormone treatment in juvenile chronic arthritis.

The Journal of rheumatology·2000

Same author

Prognosis in juvenile arthritis.

Advances in experimental medicine and biology·1999

Same author

Cutaneous vasculitis in children.

Clinics in dermatology·1999

Same journal

GRAPPA 2019 Research Recipient Awards Report.

The Journal of rheumatology. Supplement·2021

Same journal

GRAPPA Treatment Recommendations: An Update From the 2020 GRAPPA Annual Meeting.

The Journal of rheumatology. Supplement·2021

Same journal

GRAPPA Patient Research Partner Network: Update to the GRAPPA 2020 Annual Meeting.

The Journal of rheumatology. Supplement·2021

Same journal

Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group.

The Journal of rheumatology. Supplement·2021

Same journal

GRAPPA 2020 Update From the Education Committee.

The Journal of rheumatology. Supplement·2021

Same journal

The Role of Ultrasound in Research and Clinical Practice in Psoriatic Arthritis: Highlights From the GRAPPA Ultrasound Workshop.

The Journal of rheumatology. Supplement·2021

See all related articles

Area of Science:

Pediatric Rheumatology
Immunology
Dermatology

Background:

Juvenile dermatomyositis (JDM) is a rare multisystem autoimmune disease.
Characterized by nonsuppurative myositis, rash, and vasculitis affecting various organs.
Etiology is unknown, possibly linked to viral infections.

Purpose of the Study:

To provide a comprehensive overview of Juvenile Dermatomyositis.
To discuss its clinical manifestations, diagnostic markers, and management strategies.

Main Methods:

Literature review of JDM characteristics, diagnosis, and treatment.
Analysis of clinical presentation, laboratory findings (creatine phosphokinase, erythrocyte sedimentation rate, antinuclear antibodies, von Willebrand's factor 8 antigen), and complications.

Related Experiment Videos

Discussion of therapeutic approaches, including corticosteroid use.

Main Results:

JDM presents acutely or subacutely with symmetrical muscle weakness and rash.
Elevated creatine phosphokinase and presence of antinuclear antibodies are common.
Vasculitis can lead to gastrointestinal, myocardial, or lung involvement; calcinosis occurs in about two-thirds of patients.
Prognosis has improved, but mortality can occur from complications like myocarditis or bowel perforation.

Conclusions:

JDM is a serious illness requiring prompt and adequate treatment.
Early corticosteroid therapy is vital for controlling muscle inflammation.
Ongoing research is needed to fully elucidate its etiology and optimize management.